Presented by:
Arnold Chin, M.D., Ph.D.
Assistant Professor, Department of Urology
Member, JCCC Tumor Immunology and GU Oncology Program Areas
Broad Stem Cell Research Center

Dr. Arnold Chin’s research focuses on understanding how the immune system recognizes tumors in order to harness these pathways to develop novel immune-based therapeutics towards bladder and prostate cancer. Current research involves understanding the mechanisms of TLRs in anti-tumor activity and developing agonists of these receptors for use in clinical trials. Chin’s laboratory is also examining a Listeria monocytogenes-based vector that can selectively express tumor antigens for use in tumor vaccines. Initially developed in a prostate cancer model, they are adapting its use in a bladder cancer model.

Light lunch served

Sponsored by the JCCC Cancer Nanotechnology Program Area